On August 25-27, 2023, the three-day Guangzhou Medical and Health Industry Expo successfully concluded, attracting a total of 51000 exhibitors, purchasers, professional visitors, media, and practitioners to visit and exchange ideas. More than 3 million online visitors attended the exhibition, witnessing this annual medical and health event together.

As the main unit of the medical and health industry chain in Guangzhou, Daan Gene has been invited to participate in the exhibition as a leader in the domestic molecular diagnosis field, helping to promote the high-quality development of the health industry in the Greater Bay Area and contributing to the national livelihood and health project.

Da'an Gene Booth is divided into seven sub areas: core main promotion area, ultra high sensitivity hepatitis B overall solution area, molecular diagnosis area, biochemical immunity area, innovative experience area, POCT area and reagent display area. It comprehensively displays the "sophisticated" products and innovative diagnosis overall solutions of molecular diagnosis, immune diagnosis, biochemical diagnosis, mass spectrometry diagnosis and other multi technology platforms.

The breakthrough innovation in the field of molecular diagnosis, Stream Insight96, which was newly released in March this year, made a significant appearance at this exhibition. It is a fully automated nucleic acid testing and analysis system independently developed by Daan Gene, which integrates the process of sample original tube machine, nucleic acid extraction, and nucleic acid amplification detection. It truly realizes the fully automated process of "sample in, result out" and further improves the automation level of nucleic acid testing. The launch of Stream Insight96 not only enriches the layout of Daan Gene's molecular diagnosis products, but also leads the intelligence and integration of molecular diagnosis onto the "fast lane", marking a significant leap in Daan Gene's technology in the field of molecular diagnosis.

Based on independent innovation, Daan Gene has achieved horizontal and vertical coverage of the entire PCR industry chain, including research and development and production, core raw materials, quality control products, instrument research and development and production, and testing services. After thirty years of accumulation, Daan Gene has now involved molecular diagnostic technology, immune diagnostic technology, biochemical diagnostic technology, POCT, flow cytometry, NGS and other diagnostic technologies, fully covering the field of IVD.